Components List:
A2M Fibrinogen Concentrate is a specialized kit designed to provide a concentrated solution of Alpha-2-Macroglobulin (A2M) and Fibrinogen Proteins, offering at least 6x concentration. A2M, a naturally occurring protein in the blood, is known for its protective properties against destructive proteins, making it an essential component in tissue protection and regeneration.
Key Features:
Advanced Ultrafiltration System: The CORE™ Ultrafiltration System, manufactured by EmCyte Corporation concentrates platelet-poor plasma proteins from a small sample directly at the point of care, providing a streamlined and efficient process for healthcare providers.
Applications: A2M Fibrinogen Concentrate is ideal for medical and therapeutic applications where tissue protection and protein concentration are crucial. Its advanced design and high-concentration capabilities make it a valuable tool for enhancing patient outcomes.
A2M Fibrinogen Concentrate utilizes a ≥6x concentration of Alpha-2-Macroglobulin (A2M) to effectively neutralize destructive proteins in the blood. This high concentration ensures enhanced tissue protection, making it a critical component in regenerative medicine and therapeutic applications.
The CORE™ Ultrafiltration System is designed to concentrate platelet-poor plasma proteins, including A2M and Fibrinogen, directly at the point of care. This advanced technology ensures that healthcare providers can produce a highly concentrated A2M solution efficiently, optimizing tissue protection and improving patient outcomes.
The CORE™ Ultrafiltration System provides efficient protein concentration and a comprehensive set of syringes and accessories. These features make it an ideal solution for clinicians focused on tissue regeneration and protection.
